Published in J Clin Cell Immunol on April 22, 2014
Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus. Autoimmune Dis (2016) 0.80
Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis. Dis Markers (2015) 0.77
Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus Erythematosus. Malays J Med Sci (2016) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02
A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med (2001) 4.92
Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera. Biochem J (1972) 4.06
The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry (1971) 2.96
C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med (1971) 2.43
Complement: a unique innate immune sensor for danger signals. Mol Immunol (2004) 2.42
C1q, autoimmunity and apoptosis. Immunobiology (2002) 1.94
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum (2011) 1.62
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res (2010) 1.49
IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol (1991) 1.48
Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients. Rev Bras Reumatol (2012) 1.45
Do circulating antibodies against C1q reflect the activity of lupus nephritis? Pol Arch Med Wewn (2011) 1.40
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis (1995) 1.29
Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus (2010) 1.28
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.19
Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.18
Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun (2014) 1.18
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant (2006) 1.17
Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med (2009) 1.17
Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis (2001) 1.15
Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis (2008) 1.15
Consequence of neo-antigenicity of the 'altered self'. Rheumatology (Oxford) (2008) 1.14
Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis (1993) 1.12
Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum (1999) 1.07
Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum (2006) 1.06
Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum (1999) 1.05
IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum (1990) 1.04
Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol (1999) 1.03
Biomarkers for systemic lupus erythematosus. Transl Res (2012) 1.01
C1q--how many functions? How many receptors? Trends Cell Biol (1998) 0.99
Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles. Kidney Int (1997) 0.99
Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus (2004) 0.99
Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol Int (2011) 0.98
Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ther (2009) 0.97
High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol (2002) 0.97
The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol (2002) 0.96
Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus. J Clin Lab Anal (2009) 0.95
Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis (2010) 0.93
Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol (1992) 0.93
Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation. Biochemistry (1998) 0.93
Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Clin Rheumatol (2003) 0.93
Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol (1982) 0.92
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant (2008) 0.92
C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int (2009) 0.91
Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann N Y Acad Sci (2005) 0.90
Update on the management of lupus nephritis: let the treatment fit the patient. Nat Clin Pract Rheumatol (2008) 0.89
Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol (2007) 0.88
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88
Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Lupus (2012) 0.88
Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin Rheumatol (2011) 0.88
Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity. Clin Exp Immunol (1994) 0.87
Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis. Rheumatology (Oxford) (2000) 0.87
Lupus nephritis flares. Lupus (2005) 0.87
Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus (2006) 0.86
Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics (2006) 0.85
IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol (1997) 0.84
Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus. J Rheumatol (1997) 0.84
Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis (1999) 0.83
Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J Rheumatol (2010) 0.82
Autoantibodies: markers of disease or pathogenic? Ann N Y Acad Sci (1997) 0.82
Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Mol Immunol (2009) 0.81
Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients. Indian J Nephrol (2012) 0.81
Fc γ RIIA Genotypes and Its Association with Anti-C1q Autoantibodies in Lupus Nephritis (LN) Patients from Western India. Autoimmune Dis (2010) 0.80
Altered (oxidized) C1q induces a rheumatoid arthritis-like destructive and chronic inflammation in joint structures in arthritis-susceptible rats. Clin Immunol Immunopathol (1997) 0.78
Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med (2012) 0.76
The lupus biomarker odyssey: one experience. Methods Mol Biol (2014) 0.76
Detection and characterization of autoantibodies against modified self-proteins in SLE sera after exposure to reactive oxygen and nitrogen species. Methods Mol Biol (2014) 0.76
Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Nephron Clin Pract (2011) 0.76